Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Closed (Verres needle) vs. open (Hasson cannula) approach to creating pneumoperitoneum in laparoscopic cholecystectomy in patients with no previous abdominal surgery: A systematic review and meta-analysis.
Venkatachalapathi AK, Ayoub G, Ameer SA, Ghanem M, Mohammed AG, Gador M, Emoshe T, Tefera ST, Hossam Y, Hamza N, El-Sadaany F, Nashwan AJ, Hafez W. Venkatachalapathi AK, et al. Among authors: ayoub g. Curr Probl Surg. 2024 Dec;61(12):101634. doi: 10.1016/j.cpsurg.2024.101634. Epub 2024 Sep 21. Curr Probl Surg. 2024. PMID: 39647964 Free article. Review. No abstract available.
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.
Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, Desai A, Lustig RA, Bagley S, Wong ET, Hertan LM, McCluskey C, Hayden J, Muzikansky A, Nakhawa S, Japo J, Bossi CC, Meylan M, Tian Y, Barlow GL, Speliakos P, Ayoub G, Meredith DM, Ligon KL, Haas-Kogan D, Huang K, Wucherpfennig KW, Wen PY, Reardon DA. Iwamoto FM, et al. Among authors: ayoub g. Clin Cancer Res. 2025 Jan 17;31(2):316-327. doi: 10.1158/1078-0432.CCR-24-1629. Clin Cancer Res. 2025. PMID: 39513953 Clinical Trial.
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma.
Rendo V, Lee EQ, Bossi C, Khuu N, Rudek MA, Pal S, Reynolds ARN, Fassinou ACR, Ayoub G, Lapinskas E, Pisano W, Jeang J, Stopka SA, Regan MS, Spetz J, Desai A, Lieberman F, Fisher JD, Pelton K, Huang RY, Nabors LB, Holdhoff M, Danda N, Strowd R, Desideri S, Walbert T, Ye X, Agar NYR, Grossman SA, Alexander BM, Wen PY, Ligon KL, Beroukhim R. Rendo V, et al. Among authors: ayoub g. medRxiv [Preprint]. 2024 Aug 14:2024.08.12.24311893. doi: 10.1101/2024.08.12.24311893. medRxiv. 2024. PMID: 39211865 Free PMC article. Preprint.
83 results